NEUMOLOGÍA PEDIÁTRICA

Revista Neumología Pediátrica | Contenido disponible en www.neumologia-pediatrica.cl 73 Neumol Pediatr 2021; 16 (2): 69 - 74 Actualización en bronquiolitis aguda Hospitalizations. Pediatrics 2020;146(5):e20201537. doi: 10.1542/peds.2020-1537. 17. Rodríguez-Martínez CE, Castro-Rodriguez JA, Nino G, Mi- dulla F. The impact of viral bronchiolitis phenotyping: Is it time to consider phenotype-specific responses to indivi- dualize pharmacological management?. Paediatr Respir Rev 2020;34:53-8. doi: 10.1016/j.prrv.2019.04.003. 18. Schroeder AR, Marmor AK, Pantell RH, Newman TB. Impact of pulse oximetry and oxygen therapy on length of stay in bronchiolitis hospitalizations. Arch Pediatr Adolesc Med 2004;158:52730. doi: 10.1001/archpedi.158.6.527. 19. Choi J, Lee GL: Common pediatric respiratory emergencies. Emerg Med Clin North Am 2012;30:529-63. doi: 10.1016/j. emc.2011.10.009. 20. Parikh K, Hall M, Teach SJ: Bronchiolitis Management Befo- re and After the AAP Guidelines. Pediatrics 2014;133:e1-7. doi: 10.1542/peds.2013-2005. 21. Ferronato AE, Gilio AE, Ferraro AA, Paulis M, Vieira SE: Etio- logical diagnosis reduces the use of antibiotics in infants with bronchiolitis. Clinics (Sao Paulo) 2012;67:1001-6. doi: 10.6061/clinics/2012(09)03. 22. Swingler GH, Hussey GD, Zwarenstein M. Randomised controlled trial of clinical outcome after chest radiogra- ph in ambulatory acute lower-respiratory infection in children. Lancet 1998;351:404-8. doi: 10.1016/S0140- 6736(97)07013-X. 23. Schuh S, Lalani A, Allen U, Manson D, Babyn P, Stephens D, et al. Evaluation of the utility of radiography in acute bronchiolitis. J Pediatr 2007;150:429-33. doi: 10.1016/j. jpeds.2007.01.005. 24. Mahabee-Gittens EM, Bachman DT, Shapiro ED, Dowd MD: Chest radiographs in the pediatric emergency department for children < or = 18 months of age with wheezing. Clin Pediatr (Phila) 1999;38:395-9. doi: 10.1177/000992289903800703. 25. Willson DF, Horn SD, Hendley JO, Smout R, Gassaway J. Effect of practice variation on resource utilization in infants for viral lower respiratory illness. Pediatrics 2001;108:851- 5. doi: 10.1542/peds.108.4.851. 26. Wang EE, Law BJ, Boucher FD, Stephens D, Robinson L, Dobson S, et al. Pediatric Investigators Collaborative Ne- twork on Infections in Canada (PICNIC). Study of admis- sion and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1996;129:390-5. doi: 10.1016/s0022- 3476(96)70071-9. 27. Brand PLP, Vaessen-Verberne AAPH. Differences in management of bronchiolitis between hospitals in the Netherlands. Eur J Pediatr 2000;159:343-7. doi: 10.1007/ s004310051284. 28. Zielińska A, Jassem-Bobowicz JM, Kwiatkowska J. Oxygen therapywith high-flownasal cannulas in childrenwith acu- te bronchiolitis. Anaesthesiol Intensive Ther 2019;51:51-5. doi: 10.5603/AIT.2019.0010. 29. RojasMX, Granados Rugeles C, Charry-Anzola LP. Oxygen therapy for lower respiratory tract infections in children be- tween 3 months and 15 years of age. Cochrane Database Syst Rev 2009;21:CD005975. doi: 10.1002/14651858. CD005975. 30. Unger S, Cunningham S: Effect of oxygen supplementa- tion on length of stay for infants hospitalized with acute viral bronchiolitis. Pediatrics 2008;121:470-5. doi: 10.1542/ peds.2007-1135. 31. Khoshoo V, Edell D. Previously healthy infants may have increased risk of aspiration during respiratory syncytial viral bronchiolitis. Pediatrics 1999;104:1389-90. doi: 10.1542/ peds.104.6.1389 32. Oakley E, Babl FE, Acworth J, Borland M, Kreiser D, Neut- zeet J et al. A prospective randomised trial comparing nasogastric with intravenous hydration in children with bronchiolitis (protocol): the comparative rehydration in bronchiolitis study (CRIB). BMC Pediatr 2010;10:37-40. doi: 10.1186/1471-2431-10-37. 33. Kennedy N, Flanagan N: Is nasogastric fluid therapy a safe alternative to the intravenous route in infants with bron- chiolitis?. Arch Dis Child 2005;90:320-1. doi: 10.1136/ adc.2004.068916. 34. Oakley E, Borland M, Neutze J, Aworth J, Krieser D, Dalziel S, et al. Paediatric Research in Emergency Departments In- ternational Collaborative (PREDICT): Nasogastric hydration versus intravenous hydration for infants with bronchiolitis: a randomised trial. Lancet Respir Med 2013;1:113-20. doi: 10.1016/S2213-2600(12)70053-X. 35. Babl FE, Sheriff N, Neutze J, Borland M, Oakley E. Bron- chiolitis management in pediatric emergency depart- ments in Australia and New Zealand: a PREDICT study. Pediatr Emerg Care 2008;24:656-8. doi: 10.1097/PEC. 0b013e318188498c. 36. Gozal D, Colin AA, Jaffe M, Hochberg Z. Water, electrolyte, and endocrine homeostasis in infants with bronchiolitis. Pediatr Res 1990;27:204-9. doi: 10.1203/00006450- 199002000-00023. 37. Gadomski AM, Scribani MB. Bronchodilators for bronchio- litis. Cochrane Database Syst Rev. 2014;6 CD001266. doi: 10.1002/14651858.CD001266.pub4. 38. Hartling L, Bialy LM, Vandermeer B, Tjosvold L, Johnson D, Plint A, eta l. Epinephrine for bronchiolitis. Cochrane Data- base Syst Rev 2011;6:CD003123. doi: 10.1002/14651858. CD003123.pub3. 39. Fernandes RM, Bialy LM, Vandermeer B. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 2013;(6):CD004878. doi: 10.1002/14651858.CD004878.pub4. 40. van Woensel JB, van Aalderen WM, de Weerd W, Jansen N, van Gestel JP, Markhorst DG, et al. Dexamethaso- ne for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax 2003;58:383-7. doi: 10.1097/CCM. 0b013e318218a030. 41. Plint AC, Johnson DW, Patel H, Wiebe N, Correll R, Brant R, et al. Pediatric Emergency Research Canada (PERC): Epinephrine and dexamethasone in children with bron- chiolitis. N Engl J Med 2009;360:2079-89. doi: 10.1056/ NEJMoa0900544. 42. Plint AC, Grenon R, Klassen TP, Johnson DW. Bronchodi- lator and steroid use for the management of bronchiolitis in Canadian pediatric emergency departments. CJEM 2015;17:46-53. doi: 10.2310/8000.2013.131325. 43. Chao LC, Lin YZ, Wu WF, Huang FY. Efficacy of nebulized budesonide in hospitalized infants and children younger than 24 months with bronchiolitis. Acta Paediatr Taiwan 2003;44:332-5. 44. Luo Z, Liu E, Luo J. Nebulized hypertonic saline/salbuta- mol solution treatment in hospitalized children with mild tomoderate bronchiolitis. Pediatr Int 2010;52:199-202. doi: 10.1111/j.1442-200X.2009.02941.x 45. Flores P, Mendes AL, Neto AS. A randomized trial of nebu- lized 3%hypertonic salinewith salbutamol in the treatment of acutebronchiolitis inhospitalized infants. Pediatr Pulmo- nol 2016;51:418-25. doi: 10.1002/ppul.23306. 46. Everard ML, Hind D, Ugonna K, Freeman J, Bradburn M, Cooper C, et al. SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitali- sed with acute bronchiolitis. Thorax 2014;69:1105-12. doi: 10.1136/thoraxjnl-2014-205953. 47. Zhang L, Mendoza-Sassi RA, Klassen TP, Wainwright C. Nebulized hypertonic saline for acute bronchiolitis: a sys- tematic review. Pediatrics 2015;136:687-701. doi: 10.1542/ peds.2015-1914. 48. Maguire C, Cantrill H, Hind D, Bradburn M, Everard M. Hypertonic saline (HS) for acute bronchiolitis: systematic review and meta-analysis. BMC Pulm Med 2015;15:148- 54. doi: 10.1186/s12890-015-0140-x. 49. Brooks CG, Harrison WN, Ralston SL. Association between hypertonic saline and hospital length of stay in acute viral bronchiolitis: a reanalysis of 2meta-analyses. JAMAPediatr 2016;170:577-84. doi: 10.1001/jamapediatrics.2016.0079. 50. Zhang L, Mendoza-Sassi RA, Klassen TP, Wainwright C. Nebulized Hypertonic Saline for Acute Bronchiolitis: A Sys- tematic Review. Pediatrics 2015;136:687-701. doi: 10.1542/ peds.2015-1914. 51. Chandelia S, Kumar D, Chadha N, Jaiswal N. Magne- sium sulphate for treating acute bronchiolitis in children up to two years of age. Cochrane Database Syst Rev 2020;12:CD012965. doi: 10.1002/14651858.CD012965. pub2. 52. King VJ, Viswanathan M, Bordley WC, Jackman A, Sutton S, Lohr K, et al. Pharmacologic treatment of bronchio- litis in infants and children. Arch Pediatr Adolesc Med 2004;158:127-37. doi: 10.1001/archpedi.158.2.127. 53. Bradley JS, Conner JD, Compagiannis LS, Eiger LL. Expo- sure of health care workers to ribavirin during therapy for respiratory syncytial virus infections. Antimicrob Agents Chemother 1990;34:668-70. doi: 10.1128/aac.34.4.668. 54. Levine DA, Platt SL, Dayan PS, Macias C, Zorc J, Krief W, et al. Risk of serious bacterial infection in young febrile in- fants with respiratory syncytial virus infections. Pediatrics 2004;113:1728-34. doi: 10.1542/peds.113.6.1728. 55. Titus MO, Wright SW. Prevalence of serious bacterial infections in febrile infants with respiratory syncytial vi- rus infections. Pediatrics 2003;112:282-4. doi: 10.1542/ peds.112.2.282. 56. Purcell K, Fergie J. Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections. Arch Pe- diatr Adolesc Med 2002;156:322-4. doi: 10.1001/archpe- di.156.4.322. 57. Davies HD, Matlow A, Petric M, Glazier R, Wang EE. Pros- pective comparative study of viral, bacterial and atypical or- ganisms identified in pneumonia and bronchiolitis in hospi- talized Canadian infants. Pediatr Infect Dis J 1996;15:371-5. doi: 10.1097/00006454-199604000-00017. 58. Shazberg G, Revel-Vilk S, Shoseyov D, Ben-Ami A, Klar A, Hurvitz H. The clinical course of bronchiolitis associa- ted with otitis media. Arch Dis Child 2000;83:317-9. doi: 10.1136/adc.83.4.317. 59. McCallum GB, Morris PS, Chatfield MD, Maclennan C, White A, Sloots T. A single dose of azithromycin does not improve clinical outcomes of children hospitalised with bronchiolitis: a randomised, placebo-controlled trial. PLoS One 2013;8:e74316. doi: 10.1371/journal.pone.0074316. 60. Pinto LA, Pitrez PM, Luisi F. Azithromycin therapy in hospitalized infants with acute bronchiolitis is not asso- ciated with better clinical outcomes: a randomized, dou- ble-blinded, and placebo-controlled clinical trial. J Pediatr 2012;161:1104-8. doi: 10.1016/j.jpeds.2012.05.053. 61. Beigelman A, Isaacson-Schmid M, Sajol G. Baty J, Rodri- guez O, Leege E, et al Randomized trial to evaluate azi- thromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infantswith respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 2015;135:1171-8. doi: 10.1016/j.jaci.2014.10.001. 62. Roqué M, Giné-Garriga M, Granados C, Perrotta C, Vilaró J. Chest physiotherapy for acute bronchiolitis in paedia- tric patients between 0 and 24 months old. Cochrane Database Syst Rev. 2016 Feb 1;2(2):CD004873. doi: 10.1002/14651858.CD004873.pub5. 63. Gomes GR, Donadio MVF. Effects of the use of respira- tory physiotherapy in children admitted with acute viral bronchiolitis. Arch Pediatr 2018;25:394-8. doi: 10.1016/j. arcped.2018.06.004. 64. Jat KR, Mathew JL. Continuous positive airway pressure (CPAP) for acute bronchiolitis in children. Cochrane Data- baseSyst Rev 2019;1(1):CD010473. doi: 10.1002/14651858. CD010473.pub3. 65. Lazner MR, Basu AP, Klonin H. Non-invasive ventilation for